Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Genesee & Wyoming Unveils Impressive October Traffic Data

Published 11/13/2018, 10:22 PM
Updated 07/09/2023, 06:31 AM
CSX
-
SAVE
-
GWR_old
-
AFLYY
-

Genesee & Wyoming, Inc. (NYSE:GWR) reported increase traffic volumes for October. Traffic in the month was 286,180 carloads, reflecting a 3.9% increase year over year. The railroad’s same railroad traffic (excluding carloads from the Continental European intermodal business sold in June 2018) climbed 7.1%.

Segmental Traffic

Traffic in the company’s North American operations expanded 8.1% from the year-ago figure owing to impressive growth across most of its commodity groups. Notably, the intermodal segment was the most impressive performer, with its traffic rising 77%. On the flip side, the autos & auto parts group performed disappointingly, with traffic declining 41.2% due to decreased shipments in the western and midwest regions.

Australian operations (owned 51.1% by the company) traffic improved 15.1%, courtesy of 43.5% and 24.7% traffic growth at the metallic ores and coal & coke groups, respectively. Meanwhile, traffic at the agricultural products and petroleum products group plunged 83.9% and 13.8%, respectively.

Total traffic at U.K./European operations declined 7% from the last October-level, mainly due to a 13.1% decrease in the segment’s intermodal traffic.

Zacks Rank & Key Picks

Genesee & Wyoming carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the broader Transportation sector are Air France-KLM SA (OTC:AFLYY) , CSX Corporation (NASDAQ:CSX) and Spirit Airlines, Inc. (NYSE:SAVE) , each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Shares of Air France-KLM have rallied more than 28% in the past six months, while CSX and Spirit Airlines have gained more than 44% and 43%, respectively, in a year.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

3 Medical Stocks to Buy Now

The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.

So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.

See them today for free >>



Spirit Airlines, Inc. (SAVE): Free Stock Analysis Report

Air France-KLM SA (AFLYY): Free Stock Analysis Report

CSX Corporation (CSX): Free Stock Analysis Report

Genesee & Wyoming, Inc. (GWR): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.